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Summary: 
Suburothelial myofibroblasts (sMF) are located underneath the urothelium in 
close proximity to afferent nerves and show spontaneous calcium activity in 
vivo and in vitro. They express purinergic receptors and calcium transients can 
be evoked by ATP. Therefore they are supposed to be involved in afferent 
signaling of the bladder fullness. Myofibroblast cultures, established from 
cystectomies, were challenged by exogenous ATP in presence or absence of 
purinergic antagonist. Fura-2 calcium imaging was used to monitor ATP (10-16 
to 10-4 mol/l) induced alterations of calcium activity. Purinergic receptors 
(P2X1, P2X2, P2X3) were analysed by confocal immunofluorescence. We 
found spontaneous calcium activity in 55.18% ± 1.65  (mean ± SEM) of the 
sMF (N=48 experiments). ATP significantly increased calcium activity even at 
10-16 mol/l. The calcium transients were partially attenuated by subtype 
selective antagonist (TNP-ATP, 1µM; A-317491, 1µM), and were mimicked by 
the P2X1, P2X3 selective agonist α,β-methylene ATP. The expression of 
purinergic receptor subtypes in sMF was confirmed by immunofluorescence. 
Our experiments demonstrate for the first time that ATP can modulate 
spontaneous activity and induce intracellular Ca2+ response in cultured sMF at 
very low concentrations, most likely involving ionotropic P2X receptors. These 
findings support the notion that sMF are able to register bladder fullness very 
sensitively, which predestines them for the modulation of the afferent bladder 
signaling in normal and pathological conditions. 
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1.1 Anatomy and histology of the human urinary bladder  
1.1.1 Anatomy of the human urinary bladder  
The human urinary bladder is a hollow muscular organ that serve as a main 
urinary reservoir. The adult bladder normally is able to distend gradually to a 
capacity of 400-500 ml without appreciable increase in intravesical pressure. It 
was situated retroperitoneally in the pelvic cavity posterior to the symphysis 
pubis. In females, the bladder is positioned anterior to the uterus and vagina. 
In males, the bladder neck is surrounded by the prostate inferiorly, where the 
urethra leaves the bladder. The shape and size of the bladder vary according 
to the amount of urine that the organ contains. When empty it lies within the 
pelvis; when distended it becomes ovoid and expands into the lower abdomen. 
The bladder can be divided into two parts: a body lying above the ureteral 
orifices and a base consisting of the trigone and bladder neck. The ureters and 
urethral openings outline a triangular region, the trigonum vesicae, at the base 
of the bladder. The orifices of the ureters are places at the posterolateral 
angles of the trigonum vesicaea while the internal urethral orifice is placed at 





1.1.2 Structure of the human urinary bladder wall 
The four layers of the bladder wall are the tunica serosa, muscular layer, 
submucosa and mucosa. The serous layer is derived from the visceral 
peritoneum and covers the superior surface and upper parts of the lateral 
surfaces. Fibrous adventitia, a layer of areolar connective tissue, forms the 
superficial layer of the posterior and anterior surfaces of the bladder wall. The 
tunica muscularis, also called the detrusor muscle, forms the muscular layer 
consist of three layers of unstriped muscular fibres. They are inner longitudinal, 
middle circular and outer longitudinal layers. The submucosa, a layer of loose 
connective tissue, containing many elastic fibres, connects the muscular and 
the mucous layers. The deepest layer of mucosa is composed of transitional 
epithelium with an underlying lamina propria [3-5]. The structure of the human 
bladder lamina propria is well documented; it consists of loose fibroelastic 
connective tissue containing fibroblasts, blood vassels, afferent nerve fibers, 
myofibroblast and smooth muscle cells [5, 6]. Figure 1B shows the structure of 




Fig 1 Anatomy and histology of the human urinary bladder. (A) Anatomy 
of the human urinary bladder; (B) Structure of the human urinary bladder wall 
(modified from www.TutorVista.com/Biology/Urinary Bladder Structure) 
 
1.2 Normal bladder function and bladder dysfunction  
1.2.1 Normal bladder function 
The functionally bladder contains several different structures and performs 
important functions to maintain the normal micturition cycle. The micturition 
cycle is divided into two relatively discrete phases: filling/urine storage, in 
which urine is stored at low pressure, and emptying/voiding, where the 
detrusor contracts and the outlet relaxes [7]. The cycle involves switching from 
inhibition of the voiding reflex and activation of storage reflexes to inhibition of 
the storage reflexes and activation of the voiding reflex—and back again. In 
order to have these functions, first the bladder wall must be able to stretch and 
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rearrange itself to allow an increase in bladder volume without significant rise 
in pressure. In other words, the bladder wall must be extremely compliant. 
During the initial stage of bladder filling, the bladder has relative high 
compliance because of elastic and viscoelastic properties. Second, the smooth 
muscle and intrinsic nerves have to be protected from exposure to urine by the 
urothelium, which itself must also expand readily during filling. Third, bladder 
emptying requires synchronous activation of all the smooth muscle to make 
sure completely contraction of the whole bladder [8].  
 
1.2.2 Sensory aspect 
During the micturition cycle, the sensing of bladder distension is primarily 
responsible for the following initiation of voluntarily induced emptying of the 
lower urinary tract. The most important afferents for initiating and maintaining 
normal micturition receive the convey impulses from tension, volume, and 
nociceptors located in the serosal, muscle, and urothelial and suburothelial 
layers of the bladder. In a neurologically normal adult, the sensation of filling 
and distention is what develops during filling/storage and initiates the reflexes 
responsible for emptying/voiding [9, 10]. Alterations in this finely tuned 
pathway can be responsible for significant alterations in lower urinary tract 
function. There may also be a non-neurogenic active component to the storage 
properties of the bladder. Hawthorn and coauthors [11] have suggested that an 
as yet unidentifiable relaxing factor is released from the urothelium during 
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filling and storage, and some [12, 13] have suggested that urothelium-released 
nitric oxide (NO) may have an inhibitory effect on afferent mechanisms as well 
 
1.2.3 Overactivity or hypersensitivity of bladder 
Any reasons, which are related to absolute or relative failure of bladder 
filling/urine storage and bladder emptying/voiding, can cause the bladder 
dysfunctions such as Bladder pain syndrome/interstitial cystitis (BPS/IC), 
Overactive Bladder (OAB). 
This heterogeneous spectrum of BPS/IC is still poorly defined. BPS refers to 
pain perceived in the bladder region, while IC refers to a special type of chronic 
inflammation of the bladder. The European Society for the Study of IC/BPS 
has recently suggested standardized diagnostic criteria to make it easier to 
compare different studies. It suggests BPS/IC should be diagnosed on the 
basis of pain perceived in the urinary bladder, accompanied by at least one 
other symptom, such as daytime and/or night-time urinary frequency. 
Confusable diseases should be excluded as the cause of symptoms. 
Cystoscopy with hydrodistension and biopsy may be dedicated [14]. 
Overactive Bladder (OAB) is one of the common disease which result in the 
occurrence of abnormal increases in pressure as the bladder fills and the 
patient cannot inhibit. The overactive bladder (OAB) is defined as urgency, 
with or without urge incontinence, usually with frequency and nocturia [15]. But 
the mechanism of overactive bladder (OAB) is unclear. Some hypotheses 
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have been proposed to explain the pathophysiologic basis of bladder 
overactivity. The neurogenic hypothesis states that detrusor overactivity arises 
from generalized, nerve-mediated excitation of the detrusor muscle. De Groat 
[10] conclude the central nervous mechanisms controlling the lower urinary 
tract (LUT) are organized in the brain and spinal cord as simple on-off 
switching circuits that are under voluntary control. Damage to central inhibitory 
pathways or sensitization of peripheral afferent terminals in the bladder can 
unmask primitive voiding reflexes that trigger bladder overactivity [16]; The 
myogenic hypothesis suggests that partial denervation of the detrusor may be 
responsible for altering the properties of the smooth muscle, leading to 
increased excitability and increased ability of activity to spread between cells, 
resulting in coordinated myogenic contractions of the whole detrusor [17, 18]; 
The peripheral autonomy hypothesis suggests that detrusor overactivity is a 
consequence of exaggerated expression of peripheral autonomous activity 
resulting from a shift in the balance of excitation and inhibition [19, 20].  
 
1.3 The role of functional cell types and interaction in urinary 
bladder  
Although the micturition reflex is a complicated process, it was recently 
recognized that the sensations of bladder fullness or chemical stimuli is an 
essential process in initiating the micturition reflex. Most of the symptoms, 
such as urinary urgency, increased frequency of micturition and urinary 
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incontinence can be explained by pathologically enhanced bladder filling 
sensation. Different cell types in the bladder wall, including the urothelial cells, 
detrusor smooth muscle cells and myofibroblast located underneath the 
urothelium in the lamina propria, all participate in the bladder filling and voiding 
process. 
 
1.3.1 The role of urothelium  
Urothelium is composed of at least three layers: a basal cell layer attached to a 
basement membrane, an intermediate layer, and a superficial or apical layer 
composed of large hexagonal cells (diameters of 25–250 µm) known as 
‘umbrella cells’ [21]. Historically, the bladder urothelium has only been 
considered as a simple physical barrier between urine and detrusor muscle. 
However recent studies showed that the urothelium is a responsive structure 
involved in antigen presentation, the micturition reflex, metabolic secretion, 
inflammatory regulation, and sensory afferent functioning [22-24]. The urinary 
bladder urothelium can respond to chemical and mechanical stimuli, release a 
number of chemical mediators, such as ATP, NO, substance P, and be 
involved in sensory mechanisms.   
 
1.3.2 The role of suburothelial myofibroblasts 
Recently, another cell type in the bladder lamina propria, the suburothelial 
myofibroblast (sMF), has been identified in human and other species [25-27]. 
Introduction 8 
This cell type forms a distinct layer underneath the urothelium in close vicinity 
to afferent nerves [25] with the characteristics of having fibronexus and 
intracellular stress fibers [28]. Suburothelial myofibroblasts show 
morphological and functional properties of myocytes and fibrocytes [29, 30]. In 
the human bladder, subepithelial myofibroblasts stain for vimentin and 
α-smooth muscle actin but not for desmin [26]. Suburothelial myofibroblasts 
also express gap-junction protein CX43 and form a functional syncytium [31]. 
Suburothelial MF also show spontaneous Ca2+ activity [32] [33]. In a previous 
study Scigalla et al. showed that human suburothelial myofibroblasts released 
[Ca2+] after mechanically stretching [34]. Suburothelial MF were able to 
generate intracellular Ca2+ transients in response to exogenous ATP 
application [35] and several purinergic receptors were also observed in sMF 
[36, 37]. These circumstances make their role as a sensor for bladder filling 
status conceivable. However, the function of myofibroblast-like cells in the 
bladder wall is still unclear. Therefore a closer view on these cells could help to 
understand the controlling of the normal and pathologic human bladder 
function .  It is hypothesized that the location of sMF and their responsiveness 
to ATP place them in an ideal position between urothelium and nerve endings 
to act as modulators of sensory processes to either bladder fullness, or other 
(possibly pathologic) conditions which cause the urothelium to release 
transmitters such as ATP.  
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1.3.3 The role of detrusor smooth muscle cells 
The individual smooth muscle cells in the bladder wall are small 
spindle-shaped cells with a central nucleus; fully relaxed, they are several 
hundred micrometers long with a 5- to 6-µm maximum diameter [38]. Smooth 
muscle cells contain actin and myosin, but these proteins are not arranged in a 
regular sarcomere pattern. Instead, each smooth muscle cell consists of a 
more variable matrix of contractile proteins that is attached to the plasma 
membrane at the junctional complexes between neighboring cells [39]. The 
detrusor smooth muscle cells are one of the most importart cell types to 
participate the normal and pathologic micturition cycle. Detrusor contraction is 
controlled by a dense network of parasympathetic motor nerves which 
originate in the sacral (S2–S4) spinal cord and relay in pelvic ganglia near the 
bladder base and throughout the bladder wall [40]. Several Muscarinic and 
purinergic receptors were found in detrusor smooth muscle [41, 42]. These 
cells also show spontaneous activity in vivo and in vitro [43]. Detrusor smooth 
muscle cells can form functional syncytia by gap junction coupling. The 
formation of functional syncytia may modulate detrusor sensitivity and 
spontaneous activity as recent studies have demonstrated [44, 45]. Modulation 
of the size of the functional syncytia might be involved in the pathophysiology 




1.3.4 Possible interactions in urinary bladder cell types 
As the role of functional cell types we mentioned, we hypothesize that the 
different cell types in the urinary bladder wall interact to modulate the 
sensation process during the bladder filling. Studies have shown that both 
afferent and autonomic efferent nerves are located in close proximity to the 
urothelium [48, 49].  The urothelium is increasingly recognized to be a 
responsive structure that is capable of detecting physiological and chemical 
stimuli, and of releasing a number of signalling molecules. Several substances 
are released from urothelial cells following physical and chemical stimulation: 
ATP, NO, substance P, cytokines, prostanoids and various trophic factors 
[50-52]. Then, the myofibroblast, which are located underneath the urothelium 
and also in close vicinity with afferent nerves, can be activated by ATP and 
other signalling molecules [35]. Therefore, the myofibroblast could act as an 
intermediary in urothelium–afferent nerve interactions. Ultimately the 
contraction of smooth muscle cells can be motivated by efferent nerves which 
can receive the signal from afferent nerves or modulated directly by sMF or 
urothelial cells. Figure 2 show the hypothetical model about possible 
interactions between bladder afferent and efferent nerves, urothelial cells, 





Fig 2 Hypothetical model that depicts possible interactions between bladder 
afferent and efferent nerves, urothelial cells, smooth muscle and 
myofibroblasts. (modified from Birder et al 2007)[53].  
 
1.4 ATP function and Purinergic signalling in bladder 
 
Adenosine-5'-triphosphate (ATP) is a multifunctional nucleotide used in the 
cells by energy-requiring (endothermic) processes and can be generated by 
energy-releasing (exothermic) processes. It is often called the “molecular unit 
of currency” of intracellular energy transfer [54]. ATP transports chemical 
energy within cells for metabolism. It is produced by photophosphorylation and 
cellular respiration and used by enzymes and structural proteins in many 
cellular processes, including biosynthetic reactions, motility, and cell division.  
ATP is also a signalling molecule. ATP, ADP, or adenosine are recognised by 
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purinergic receptors. Purinoreceptors might be the most abundant receptors in 
mammalian tissues [55]. In humans, this signalling role is important in both the 
central and peripheral nervous system. ATP acts on two families of purinergic 
receptors: an ion channel family (P2X) and a G protein–coupled receptor 
family (P2Y) [56] [57]. Seven P2X subtypes and eight P2Y subtypes have 
been identified. Analysis of the structure-activity relationships of a series of 
excitatory purinergic agonists on the guinea pig bladder revealed an order of 
potency consistent with P2X1 or P2X2 receptors [58, 59]. In other species 
(rabbit, cat, and rat), various studies suggested that multiple purinergic 
receptors are present in the bladder [60]. Immunohistochemical experiments 
with specific antibodies for different P2X receptors showed that P2X1 
receptors are the dominant subtype in membranes of rat detrusor muscle in 
the bladder [61]. Clusters of P2X1 receptors were detected on rat bladder 
smooth muscle cells, some of which were closely related to nerve varicosities. 
Northern blotting and in situ hybridization revealed the presence of P2X1 and 
P2X4 mRNA in the bladder [62]. The predominant expression of P2X1 
receptors has also been confirmed in the human bladder [63]. Investigators 
also found that the amount of P2X1 receptors was increased in the obstructed 
bladder compared with the control bladder, suggesting upregulated purinergic 
mechanisms in the overactive bladder due to bladder outlet obstruction [64]. 
ATP, one of the most important neurotransmitters, is released from the 
urethelium during bladder distension [65-67]. It is supposed that it is the first 
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step in the excitation of bladder afferents as the bladder fills with urine. This 
hypothesis is strengthened by the localization of P2X3 receptors on 
suburothelial nerves [61] and the fact that the micturition reflex was reduced in 
P2X3 knockout mice [68, 69]. But the purinergic singnalling in the suburothelial 
myofibroblast of the human bladder is still unclear. 
 
1.5 Spontaneous activity of bladder 
In addition, under pathologic feature such as OAB, BPS/IC, the bladder have 
the characteristics of spontaneous transients rise in intravesical pressure 
during the filling phase prior to the micturition. Recently the autonomous 
activity or the non-micturition activity was described in vitro artifact of guinea 
pig [19] and the rat [70]. These spontaneous activities were also confirmed in 
vivo experiments which investigated the non-micturition contractions in the 
bladder of the anaesthetized and awake rat [71]. In a rat model for detrusor 
overactivity, local areas of spontaneous contractions are increased and more 
coordinated in partial outlet-obstructed rat bladders [19]. Such autonomous 
activity can be augmented by the application of muscarinic agonist [72] and 
also be regulated by the nonhydrolysable analogue of ATP, α,β-methylene 
ATP and the sensory peptide, substance P [73]. These observations indicated 
that differring from activating detrusors during micturitions, it is a second 
system within the bladder which has the potent ability to generate afferent 
signalling and linked with bladder sensations. However, it is still not clear 
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which cells generate spontaneous activity in the bladder. The detrusor 
myocytes could be spontaneously active, and electrical coupling through gap 
junctions could trigger spontaneous contractions [45] [44]. Alternatively, 
another population of cells in the bladder known as interstitial cells or 
myofibroblasts has been proposed for a pacemaking role in spontaneous 
activity of the bladder [74, 75]. In order to gain spontaneous activity, it is 
necessary that some cells must be spontaneously active and have the 
capability to initiate the autonomous activity.  
Ca2+ is the most versatile intracellular messenger which is involved in the 
regulation of almost all known cellular functions and reactions. Thus 
intracellular calcium activity is an ideal target to reflect the contractile activity of 
bladder. 
Since ATP concentration is likely to be very low during the initial filling phase, 
we hypothesize that sMF Ca2+ activity is affected at very low ATP 
concentrations to enhance spontaneous activity and allow for amplification of 
the afferent signalling through cells coupling in its response to ATP, in 
consequence via spinal / supraspinal circuits or local circuits to enhance 
efferent nerve activity which would promote contractions in vivo. Thus the 
detrusor activity during normal miturition process and spontaneous detrusor 




The present study was accomplished to investigate ATP induced modulation 
of spontaneous activity, intracellular calcium response, and purinergic 
signalling in cultured human suburothelial myofibroblasts.
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3 Material and methods 
 
3.1. Ethics Statement 
The study was approved by the Ethics Committee of the University of Leipzig 
(#036--2007) and was conducted according to the principles expressed in the 
Declaration of Helsinki. Written informed consent was obtained from all 
patients. 
 
3.2 Cell preparation 
We used tumor free bladder tissue samples from patients undergoing radical 
cystectomy due to bladder cancer. For setup of suburothelial myofibroblast cell 
cultures (hsMF) we separated the urothelial layer by sharp dissection, 
ensuring no contamination with detrusor smooth muscle cells. Thus aSMCA 
and vimentin positive cells were the most abundant cell population besides 
urothelial cells in this part of the bladder (Fig. 3). CD117 positive interstitial 
cells of Cajal (ICC) were only sparse in human bladder lamina propria and 
therefore cannot account for the majority of the cultured suburothelial 
myofibroblasts (Fig. 3 C-D). Small tissue fragments (0.5x0.5x0.5 mm) were 
plated into tissue culture flasks (TPP AG, Trasadingen, Switzerland) and 
incubated at 37°C and 5% CO2 in SMC Growth Medium 2 (PromoCell GmbH, 
Heidelberg, Germany) and subcultured up to the third passage (P3). The 
growing cells showed typical morphological and immunocytochemical features 
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of myofibroblasts as recently described [76]. The use of special smooth muscle 
cell growth medium was sufficient to avoid growth of urothelial cells as proven 
by visual phase contrast (Fig. 4). In immunocytochemical stainings no 
cytokeratin-positive cells were detected (data not shown). This isolation and 
culture method ensured that sMF represented the vast majority of cells in our 
cell cultures. For calcium imaging experiments cells were plated onto 13mm 
glass coverslips coated with collagen A (Biochrome AG, Berlin, Germany) and 
grown to a confluence of about 80% for the calcium imaging experiments. The 
data shown were obtained from three different primary batches of cells. 
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Fig 3. Distribution and immunocytochemistry of suburothelial 
myofibroblasts. Human unaltered bladder paraffin sections were incubated 
over night with monoclonal mouse antibodies: anti-aSMCA (IgG2a, 1:2000; 
Sigma-Aldrich), anti-vimentin (1:100; Sigma-Aldrich) or anti-CD117 (c-Kit, 
1:100; DAKO, Glostrup, Denmark) and visualized with Envision-Kit™ (DAKO) 
using AEC substrate chromogen (3-Amino-9-ethylcarbazole in 2.5% 
N,N-dimethylformamide; red color). Nuclei were stained with Mayer’s 
hematoxylin. (A) Numerous aSMCA positive cells are present in the lamina 
propria directly underneath the urothelium. The staining pattern resembles that 
of vimentin (B). CD117 immunoreactivity was confined to only few 
suburothelial elongated cells (C, arrowheads) and to cells in-between smooth 
muscle cell bundles (D, arrows). Urothelial cells regularly showed light CD117 
immunoreactivity with only few more intensely stained elongated cells within 
the urothelial cell layer (arrow in C). (E) Staining control showed no AEC 
background staining. U – Urothelium; the scale bar in D indicates 100 µm and 
applies to A-E. 
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Fig 4. Cell culture morphology. Phase contrast micrographs. (A) Typical 
suburothelial myofibroblast culture; note the characteristic morphology of sMF 
in this sub-confluent cell culture; (B) urothelial cell culture demonstrating 
typical cobblestone-like morphology of human urothelial cells. The scale bar in 
B indicates 100 µm and applies to A and B. 
 
3.3 Solutions and chemicals 
We used the modified Krebs Ringer solution of the following composition (mM): 
CaCl2, 1.9; NaCl, 120.9; NaHCO3 , 14.4; KCl, 5.9;  MgCl2 ,1.2; NaH2PO4 , 
1.55; Hepes, 4.2; Glucose, 11.49; pH 7.2. All solutions were prepared freshly 
on the day of use. The following chemicals were obtained from Sigma-Aldrich, 
Steinheim, Germany: ATP，α,β-methylene ATP (me-ATP), A-317491, DMSO; 
Fura-2AM and Pluronic® were obtained from Invitrogen, Karlsruhe, Germany; 
TNP-ATP were obtained from Torcris Biosciences, Bristol, UK. All chemicals 
were diluted from in Krebs Ringer solution 10mM stock solutions stored at 
-20°C on the day of experiments. ATP and TNP-ATP were kept in the dark. All 
drugs were diluted in pure Krebs Ringer solution, which was also used for 
control in the different experimental parts. 
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3.4 Intracellular calcium measurements 
 
3.4.1 Preparing cells for Calcium Imaging  
After brief wash in ringer the coverslips were bulk-loaded with 
Fura-2-acetoxymethylester (2.5µM Fura-2AM solved in DMSO, 2% Pluronic in 
ringer; 22° C; 40 min.) at room 22° C for 40 minutes under exemption of light. 
The coverslips were subsequently washed in Krebs Ringer for 15 minutes to 
ensure cleavage of the acetomethoxy ester by endogeneous esterases. 
Thereafter, the cells were transferred to the laminar flow chamber where they 
were superfused for another 10 minutes with carbogenized ringer at a constant 
flow rate of 0.8ml/min at 37°C in the heated recording chamber (Zeiss, Jena, 
Germany) before the beginning of the recordings to allow the cells to adapt to 
experimental conditions.  
 
3.4.2 Preparing workspace of calcium imaging 
Workspace setup can usually be done while the first cell-incubation is in 
progress and depends on the experiment. Minimum components are included: 
cooled high performance camera (Imago-QE; TILL Photonics, Gräfelfing, 
Germany), inverse microscope (Olympus IX71), chamber heating device 
(tempcontrol 37-2 digital; Carl Zeiss), the laminar flow chamber, Polychrome II 
monochromator, control unit and TILLvisION (V4.0) software (TILL Photonics) 
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and a computer controlled 9-electrovalve array (EVH-9 with MEV-9; BioLogic, 
Claix, France). (Fig 5) 
 
 
Fig 5 Calcium imaging workspace. (A) high performance camera; (B) 
inverse microscope; (C) Polychrome II monochromator and control unit; (D) 
the laminar flow chamber; (E) chamber heater device; (F) EVH-9 flow device. 
 
The laminar flow chamber (RC-26G, 234µl volume; World Precision 
Instruments, Sarasota, USA) and all tubes were used under aseptic conditions. 
To reduce possible contamination, the following measures proved useful: 
alcohol cleaning of the laminar flow chamber before experiment (carefully 
Material  Methods 22 
check for leakage of chamber); rinsing all tubes properly with distilled H2O;  
usage of freshly made ringer solution; using continuous flow. 
 
3.4.3 Calcium imaging recording 
Calcium imaging recordings were carried out with a high performance cooled 
TILL IMAGO-QE camera, connected to an Olympus IX-71 inverse microscope. 
TILLvisION 4.5 (TILL Photonics) was used for camera control and data 
acquisition. Image series were recorded every second for 15 minutes with an 
excitation wavelength of 340nm and 380nm. Fura-2 fluorescence ratios were 
calculated as FI = F340nm/F380nm*1000 after dynamic background 
subtraction. 
 
3.5 Data analysis with automated Fluorescence analysis 
The recorded fluorescense videos and phase-contrast images of the observed 
section of the coverslip were transferred to ImageJ (Rasband WS (1997-2006), 
NIH USA, http://rsb.info.nih.gov/ij/), for image analysis. One circular region of 
interest (ROI) with a diameter of 8.25 µm was defined for each myofibroblast 
close to the nucleus. (Fig.6A-B).  
We used a self written ImageJ script to calculate the fluorescence intensity (FI) 
kinetics of the region of interest (ROIs). The following analysis of the calcium 
kinetics was performed with a self programmed automated fluorescence 
analysis (FA), which is a self-written script for Python 2.6 (Rossum G (2008) 
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Python/C, Python Software Foundation, http://python.org/). The FA was used 
to detect and characterize the peaks within the timecourse of the Ca2+ 
fluorescence. The automated peak detection of the FA minimized the danger 
of biased peak detection that can occur in manual peak selection. The Ca2+ 
fluorescence signal underwent a sliding average filter where each 
flourescence value was calculated as the mean of the circumfluent 5 values to 
reduce high frequent noise. 
For the detection of the peaks we used an algorithm, that detects peak starts, 
when the first derivative (ΔF340/380) of the Ca2+ signal crosses a threshold. 
This threshold was determined by the background noise. Therefore, the 
background noise was calculated for the calcium signals of each ROI in a 
manually selected intervall without any major calcium activity. (Figure 6C). 
Peak starts were defined as rise of ΔF340/380 above 2.5 times of the standard 
deviation (SD) of the corresponding background noise. To define the whole 
peak interval for each detected peak start, the program tracked the following 
local maxima after the peak start event occured. The end of the peak was 
defined as decline of the signal strength below 60% of the maximal signal 
amplitude (FImax – FIstart). Figure 6D depicts the process of peak detection. 
After detection of the signals, the FA program identifies signal characteristics 
for the whole observation intervall and for each detected peak seperately, 
including: peak amplitude and number of peaks. The identified signal 
characteristics were transferred to MS Excel for preparation of the statistical 




Fig 6: Data analysis with automated Fluorescence analysis (A) Phase 
contrast image of cultured human suburothelial myofibroblasts at about 80% 
confluency. (B) Fura-2 fluorescence image at 380 nm excitation. One circular 
region of interest (ROI) (white spots) with a diameter of 8.25 µm was defined 
for each myofibroblast close to the nucleus. (C) Automated fluorescence 
analysis for calcium kinetics. Black line: filtered fluorescence ratio (F340/380); 
Blue: interval of background noise; Peak starts were defined, when the 
signal-increase exeeded 2.5x the standard deviation of DF340/380 
(=F340/380 - background). (D) Computation of the peak intervalls. Orange: 
Detected peak intervals; the program tracked the global maximum (2) after a 
peak start (1). The end of the peak (3) was determined as decline of the signal 
strength below 60% of the signal amplitude. 
 
Since the automated peakdetection algorithm has a low specificity for the 
detection of peaks with a very low amplitude, we set a cut-off in peak 
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amplitude (ΔFI ≥ 20) and minimum peaklength (5 pictures). 
The experiments consisted of three parts of 5 minutes each (parts A, B, C; Fig. 
7). The suburothelial myofibroblasts were superfused with Ringer solution in 
Part A and C in order to assess the spontaneous activity. Cells were defined 
as ‘spontaneously active cells’ (SAC) if they show spontaneous calcium 
transients in part A of the experimental procedure. In contrast, inactive cells 
were denoted IAC. 
 
3.6 Confocal Immunofluorescence 
Cells were fixed in 4% paraformaldehyde (1h, 4°C), washed three times in 
Tris-buffered saline (TBS; pH 7.2), permeabilized for 10min with DT-TBS 
(0.08% Triton-X100 and 0.32% dimethyl sulfoxide), and blocked with 3% 
skimmed milk and 1% bovine serum albumin in TBS. Double labelling 
experiments were done with rabbit polyclonal anti-P2X1, P2X2, P2X3 (1:1000, 
immunoglobulin G, IgG, Sigma-Aldrich), and mouse monoclonal anti-aSMCA 
(1:2000, IgG2a; Sigma-Aldrich) antibodies. Alexa-fluor 488 (A-488), A-555, 
and A-633 coupled secondary antibodies (Invitrogen) diluted 1:500 in TBS (1 h, 
room temperature) were used for visualisation. Nuclei were stained with 
4',6-diamidino-2-phenylindole-dihydrochloride (DAPI; Roche Diagnostics, 
Mannheim, Germany). Immunolabelled cells were examined with a 
laser-scanning microscope (LSM5 Pascal; Zeiss, Jena, Germany). The 
purinergic receptors expression was analysed with ImageJ and MS-Excel 
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(Microsoft, Redmond, USA). 
 
3.7 Statistics    
GraphPad Prism (GraphPad 5.0 Software, Inc., San Diego, USA) was used for 
presentation and statistical analysis of the data by Student’s t-test for paired or 
unpaired data or one-way ANOVA with Tukey’s multiple comparison test. A 















4.1 Spontaneous calcium activity of sMF 
We found basic spontaneous calcium activity (Fig. 7, part A) in 55.18% ± 1.65 
of the sMF, with a mean amplitude of ΔFI = 243.9 ± 10.24 
F340nm/F380nm*1000 and an average Ca2+ peak frequency of 0.41 ± 0.01 
min-1 (n = 4039; N = 48). After part A, we switched the Ringer's solution to a 
second solution which additionally contained the substances (ATP, 
Antagonists) and recorded the reaction of the suburothelial myofibroblasts (Fig. 
7, part B).  
 
Fig 7: Calcium activity characteristics of cultured human suburothelial 
myofibroblasts (sMF). Continuous recording of calcium fluorescence intensity. 
The representative traces show two examples of calcium activity 
characteristics of sMF. Spontaneously active cells (SAC) showed initial 
spontaneous Ca2+ transients in part A. Inactive cells (IAC) showed no initial 
spontaneous Ca2+ transients in part A. 
 
4.2 ATP effects on calcium response in sMF 
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The fraction of active cells, the frequency of active cells and Ca2+ peak 
amplitude increased with increasing ATP concentrations. However, the ATP 
dose-response curve showed a bi-phasic course with an increase from 10-16 to 
10-10 mol/l and from 10-6 to 10-4mol/l and a drop to control level at 10-8 mol/l 
(Fig. 8A-C).  
 
 
Fig 8: ATP effects on calcium response in sMF. (A) fraction of active cells; 
(B) frequency of active cells; (C) mean amplitude of active cells. Data are 
expressed as mean (SEM; N=6 separate experiments). Note the bi-phasic 
dose-response curves. *p<0.05 was considered significant comparing 
ATP-stimulated cells to control (unpaired t-test). 
 
The kinetics of the calcium transients in sMF were different at low and high 
ATP concentrations. Figure 9 shows representative traces of sMF (control, 
10-12 and 10-4 mol/l ATP). The stimulation with a high ATP concentrations 
(>10-8 mol/l) typically evoked synchronous calcium transients with a rapid initial 
steep calcium rise (Fig. 9A). The response to the low ATP-concentration of 
10-12 mol/l did not show the characteristic high fist peak, which we observed at 
10-4 mol/l ATP. Instead, the first calcium rise varied considerably from cell to 
cell (Fig. 9B). However, the overall profile was similar to the cells in the control 
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experiments (Fig. 9C), except for higher peak frenquency and amplitude.  
 
Fig 9: Representative traces of intracellular calcium responses at low 
and high ATP concentrations. (A) The initial peaks emerged immediately 
after 100µM ATP stimulation. (B) Cells did not show synchronized peaks when 
challenged with 1pM ATP. However, increased numbers of small calcium 
transients occurred during ATP stimulation. (C) In control experiments 
(superflow of ringer solution without ATP) almost no significant increase of 
peaks or peak amplitudes were recorded. 
 
We analysed the mean lag time of the first peaks after addition of ATP and 
found significant differences between high and low ATP concentrations (Fig. 
10A). Also, the mean amplitude of the first peaks after high ATP application 
was significantly higher than after low ATP application (Fig. 10B). The mean 
amplitude of the first peaks was significantly higher than that of the following 
peaks at 10-4 mol/l ATP, while this was not the case at 10-12 mol/l ATP.  
Results 30 
 
Fig 10: ATP effects on spontaneous activity at low (10-12 mol/l, 1pM) and 
high (10-4 mol/l, 100µM) concentrations. (A) The mean lag time of the first 
peak after ATP stimulation was shorter at 100µM ATP application than at 1pM 
ATP application. (B) Mean amplitude of the first peak (black columns) was 
significantly higher at 100µM ATP than at 1pM ATP application. The amplitude 
of the following peaks did not differ at 1pM ATP but were significantly lower at 
100µM ATP. Note that there was no difference between the mean amplitude of 
the first peak and the following peaks at 1pM ATP stimulation. Data are 
expressed as mean (SEM; N=6). *p<0.05 was considered significant (unpaired 
t-test); § p<0.05 compared to respective control; n.s.=not significant. 
 
4.3 Analysis of purinergic receptors involved 
 
4.3.1 Agonist stimulation 
ATP-induced calcium response was mimicked by α,β-methylene ATP 
(α,β-meATP), a P2X1 and P2X3 receptors agonist, at both used 
concentrations, 1pM (10-12 mol/l) and 100µM (10-4 mol/l). While peak 
amplitudes were not different between α,β-meATP and ATP at the same 
concentrations. Area under the curve (AUC), describing the sum of elevated 




Fig 11: Agonist (α,β-methylene ATP; meATP) induced intracellular 
calcium response in sMF. (A) Mean amplitude of sMF evoked by 
α,β-methylene ATP at 1pm and 100µM was significantly increased compare to 
control experiment, while there is no significant difference compared to ATP 
induced effect. (B) The area under the curve was significantly increased 
compare to control experiment, while there is significant lower at 100uM 
meATP compared to 100uM ATP induced effect. Data are expressed as mean 
(SEM; N=2). *p<0.05 was considered significant (unpaired t-test); § p<0.05 
compared to respective control; n.s.=not significant. 
 
4.3.2 Signal inhibition by specific antagonists 
We used two different purinergic antagonists to investigate the contribution of 
P2X receptor subtypes to the response of the sMF. TNP-ATP (1µM) 
selectively inhibits P2X1, P2X3 and P2X2/3 receptors and A-317491 (1µM) 
selectively inhibits P2X3 and P2X2/3 receptors. ATP evoked calcium 
transients were partially attenuated by both purinergic antagonists. Data were 
normalized to agonist stimulation, 10-12mol/l (1pM) and 10-4mol/l (10µM) 
respectively (Fig. 12). The mean amplitude of calcium peaks was significantly 
reduced at both ATP concentrations. However, at 1pM ATP stimulation, 
TNP-ATP (74.98%) showed a significant higher inhibition than A-317491 
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(39.29%) (Fig. 12A), while at 100µM ATP stimulation the inhibition by 
TNP-ATP and A-317491 was reduced to 38.1% and 23.4%, respectively (Fig. 
12B). 
 
Fig 12: Inhibition of ATP induced intracellular calcium signals by 
purinergic receptor antagonists. (A)  Normalized amplitude of active cells 
at 1pM ATP stimulation in the presence and absence of purinergic antagonists. 
(B) Normalized amplitude of active cells at 100µM ATP stimulation in the 
presence and absence of purinergic antagonists. Data expressed as mean 
(SEM; N=3). Amplitudes were normalized (see text). These antagonists inhibit 
the ATP-induced purinergic calcium signals by a competitive mechanism. We 
seperately incubated the cells for 20 minutes with the antagonists before the 
start of the recordings. In addition, the cells were rinsed with antagonist 
containing Ringer solution. *p<0.05 was considered significant (One-way 
ANOVA, Tukey’s multiple comparison test); § p<0.05 compared to respective 
control; n.s.=not significant. 
 
4.4 Confocal immunofluorescence of purinergic receptors 
The expression of purinergic receptor subtypes in sMF was examined by 
confocal immunofluorescence (Fig. 13). Strong P2X1 (Fig. 13A) and P2X2 (Fig. 
13B) receptor immunoreactivity (IR) was seen in cultured suburothelial 
myofibroblasts of human bladder, while P2X3 receptor-IR was significantly 
lower (Fig. 13C, E). 
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Figure 13: Confocal immunofluorescence of purinergic receptors (red) 
and alpha smooth muscle cell actin (aSMCA; green) in cultured sMF. (A) 
P2X1, (B) P2X2, (C) P2X3 labeling, (D) staining control, receptor specific 
antibody omitted. (E) Quantification of purinergic receptor immunoreactivity 
using confocal laser scanning microscopy. Scale bar in B indicates 20 µm and 
applies to A-D. Data expressed as mean (SEM; n=105 cells, N=3 exp.); 
*p<0.05 was considered significant (One-way ANOVA, Tukey’s multiple 




5.1 Myofibroblast identification 
Recently, myofibroblastic cells have been identified in the lamina propria of the 
human bladder and other species [25-27]. These cells of interest are 
underneath the urothelial layer in the amorphous collagenous matrix that 
separates the urothelium from the detrusor muscle [29]. Those cells form a 
distinct layer underneath the urothelium in close vicinity to afferent nerves [25] 
and we therefore refer to as suburothelial myofibroblasts (sMF).  
It is possible to isolate suburothelial myofibroblasts from the urothelial layer by 
gentle treatment with a collagenase-containing solution. In our experiment, the 
lamina propria and urothelium is first separated from the detrusor layer by 
sharp dissection, ensuring no contamination with detrusor smooth muscle cells. 
The use of special smooth muscle cell growth medium was sufficient to avoid 
growth of urothelial cells as proven by visual phase contrast (Fig. 4). When 
initially prepared, the suburothelial cells have a spindle-shaped appearance, 
which differentiates them from the large round urothelial cells. This isolation 
and culture method ensured that sMF represented the vast majority of cells in 
our cell cultures.  
There is an ongoing discussion, whether those cells are indeed interstitial cells 
of Cajal (ICCs) as promoted by McCloskey in a recent review [30]. The first 
indication that the bladder might contain ICC came from a study by Smet et al 
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[38] who observed cyclic GMP-immunopositive cells in guinea-pig and human 
bladder which had a morphological resemblance to gut ICC. More recently, the 
presence of ICC in the bladder has been demonstrated using antibodies to the 
well established ICC marker c-Kit [77, 78]. c-Kit is a proto-oncogene that 
encodes the tyrosine kinase receptor, Kit which is expressed in ICC but not in 
smooth muscle cells or fibroblasts [79]. However, while c-kit positive cells 
resembling ICCs are numerous in guinea-pig and pig bladders they are rare in 
human bladder to our experience (Fig. 3) and literature [26, 80]. Therefore, the 
c-Kit positive cells cannot account for the majority of the cultured suburothelial 
myofibroblasts.  
Identification of characterized myofibroblasts is sometimes based on their 
cytoskeleton, according to expression of the intermediate filament proteins 
vimentin and desmin, along with αSMCA [81]. An immunohistochemical 
characterization as a spindled cell with αSMCA has been used to define a 
myofibroblast without transmission electron microscopy (TEM) in some studies 
[28]. In our experiment, alpha-smooth muscle cell actin aSMCA+/vimentin+ 
elongated cells with irregular blistered shape, which are clearly different from 
smooth muscle cells, are most frequent in the lamina propria of the human 
bladder (Fig. 3). Those characteristics of myofibroblasts are similar described 
on other studies [26, 47]. 
 
It is suggested that sMF play a role in modulating the sensor process of neither 
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bladder fullness or other pathological conditions. sMF have the spontaneous 
activity and can generate the intracellural cancium transitents by exogenous 
ATP application [35]. However, the reaction of calcium response and the effect 
on modulating the spontaneous activity by low ATP application in human sMF 
are very scarce thus far. It is therefore the objective of the present study to 
investigate ATP induced modulation of spontaneous activity, intracellular 
calcium response especially at low ATP concentration, and further investigate 
the purinergic signalling in cultured human suburothelial myofibroblasts. 
 
5.2 Spontaneous activity in the bladder 
Two levels of spontaneous activity in the bladder have to be considered; (i) 
spontaneous detrusor contractile activity, which is regularly observed in 
bladder strip organ bath preparations and whole bladders [19, 71]; (ii) calcium 
activity within the lamina propria which can evoke detrusor contractions in the 
rat bladder and speak in favor for a pacemaker activity of lamina propria 
myofibroblasts [32]. Alterations of spontaneous contractile activity of the 
bladder have been described in bladder strips from patients with idiopathic 
detrusor instability [82] and from patients with neurogenic detrusor overactivity 
[83]. In the latter, spontaneous contractile activity was not altered by removing 
the urothelium/suburothelium from the bladder strips which indicates that the 
spontaneous detrusor contractions were initialized within the detrusor itself 
[83]. In contrast, removal of the mucosa and submucosa inhibited 
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spontaneous detrusor contractions in guinea pigs [84] and pigs [85] indicating 
a different underlying mechanism of generation. 
In our experiments we found spontaneous calcium activity in 55.18% ± 1.65 of 
the cultured human sMF, which is slightly higher than the fraction of detrusor 
smooth muscle cells showing spontaneous calcium rises reported recently for 
freshly isolated cells from stable detrusor (40%) but clearly less than in cells 
from overactive bladders (74%) [43]. It is especially interesting that the 
suburothelial myofibroblasts retain a constant level of spontaneous calcium 
activity even after several cell passages in culture. 
To the best of the authors knowledge, there is no information on the number of 
spontaneous activity in human myofibroblasts. However, Wu et al. [35] found 
spontaneous inward currents, preceeded by spontaneous Ca2+ rises, in 45% 
of freshly isolated guinea pig sMF, which is in good agreement with our results 
in the long term cultured human sMF. 
 
5.3 ATP modulated calcium activity in sMF 
Several reports have documented the use of micromolar concentrations of 
ATP to elicit maximal responses of Ca2+ activity. With reference of the 
literature [86-88], we use 100µM ATP in our study as maximum ATP 
concentration. The measurements above 10-8 mol/l are consistent with the 
results described in the literature [89, 90], where the lowest ATP concentration 
that evoked calcium transients was reported to be 10-8 M level with an EC50 
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between 1 and 10µM. Our previous study reported the sMF in human bladder 
could elicit the calcium transients by 1µM ATP stimulation [33]. C.Wu et al 
investigated the calcium responding on application of exogenous ATP 
between 0.1µM and 100µM in guinea pig sMF. The lowest concentration was 
effective in eliciting a small response with a maximal response attained at 
10µM [35].  
ATP is released from urothelium during baldder filling and this signal is 
detected by sensory nerves and sMF. But it is still difficult to know the exact 
ATP concentration during the physiology process. Two studies reported that 
ATP concentration released from urothelium was at very low level (pmol/l) 
during the initial filling phase in rat bladder and cultured urothelial cells. One 
study reported that the ATP level released by distension of excised bladder or 
treatment of cultured urothelial cells with hypotonic medium was at pmol/ml 
level using the luciferin-luciferase assay [66]. The similar results was also 
displayed in Vlaskovska’s study [69].  
In the present study we demonstrated that sMF Ca2+ activity was affected at 
very low ATP concentrations. Even sub-picomolar concentrations of 
extracellular ATP therefore are potentially effective in modulation of the 
suburothelial myofibroblast activity; To the best knowledge, it is the first time to 
expound the Ca2+ activity in sMF by low ATP application. This result points out 
a possible functional connection between urothelium and sMF.  
Interestingly in our study the profile of calcium transients in sMF display a 
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different pattern at low and high ATP concentration as shown in Fig 9-10. The 
calcium transients could be evoked rapidly with a short lag time by high ATP 
concentration. This ATP induced effect was also observed on other cell types 
[91]. The first peaks have apparently higher amplitude than the other peaks 
following high ATP stimulation. While the low ATP application could not 
evoked the calcium transients directly, and the amplitude of the first peaks and 
the other peaks had no significant difference. Though those directly evoked 
calcium transients were absent at low ATP concentrations, there was still a 
significant increase in peak frequency and amplitude. This means that even 
pico-molar concentrations of ATP, as expected during initial phase of bladder 
filling, can modulate the pattern of the spontaneous activity in sMF. We 
conclude, that sMF could function as very sensitive detectors for mechanical 
stress in the bladder wall. Since we used almost confluent cell cultures the low 
ATP-effect may be a function of the whole syncytium of sMF. Further studies 
on single sMF or using gap junction inhibitors are needed to clearify this point.  
 
5.4 purinergic signalling in sMF 
ATP exerts its effects via two general classes of purinergic receptors, P2X and 
P2Y [92]. We here report the expression of P2X (P2X1, P2X2, P2X3) 
receptors in cultured human sMF, which is in agreement with our previous 
study [33]. A recent study also proved that expression of P2X3 purinoceptors 
in suburothelial myofibroblasts of the normal human urinary bladder [93]. Our 
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previous study also showed that carbachol and ATP-evoked intracellular 
calcium transients depend on extracellular calcium, implying that P2X 
receptors are involved in ATP-induced intracellular calcium transients [33]. In 
our present study, the p2X receptors expression were also confirmed by 
immunofluorescence analysis and the ATP induced calcium transients of sMF 
were mimicked by α,β-methylene ATP (P2X1, P2X3 selective agonist). As we 
mentioned before, the calcium reaction by ATP at low and high concentration 
has some different characteristics and the dose response cure show the 
bi-phasic course. It is supposed that probably more than one purinergic 
receptors participate the effection at low and high ATP application. The 
bi-phasic course of the dose-response curve could be explained with distinct 
purinergic receptors involved.  
For initial analysis we used two selective purinergic antagonists to investigate 
the contribution of P2X receptor subtypes to the response of the sMF. 
TNP-ATP used at 1µM selectively inhibits P2X1, P2X3 and P2X2/3 receptors, 
while A-317491 at 1µM selectively inhibits P2X3 receptors with negligible 
effect on P2X1 and P2X2 receptors [94, 95]. We used antagonist 
concentrations, which were 10-100 fold higher than the IC50 reported in 
literature to ensure sufficient and reproducible inhibition [94]. Calcium 
transients were only partially attenuated by all antagonists, at both low and 
high ATP concentrations.  
At high ATP concentration (100µM) we found about 20% inhibition of the signal 
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by A-317491 and about 40% inhibition by TNP-ATP (Fig. 12B). This indicates 
equal percentual contribution of P2X1 and P2X3 receptors. Interestingly the 
effects of antagonists were stronger at low ATP concentration (1pM). 
A-317491 showed about 40% inhibition and TNP-ATP inhibited up to 75% of 
the ATP induced calcium amplitude (Fig. 12A). 
Those experiments demonstrate that P2X1 and P2X3 receptors are involved in 
ATP signalling in sMF. However, there seems to be a significant part of ATP 
signal mediated by other purinergic receptors. Due to lack of available P2X2 
receptor antagonists, it remains unclear whether the P2X2 receptor is involved 
in ATP signalling as suggested by the high expression found in 




6  Summary 
The perception of bladder filling is essential for the control of bladder function. 
Most of the symptoms, such as urinary urgency, increased frequency of 
micturition and urinary incontinence can be explained by pathologically 
enhanced bladder fullness sensation.  
Suburothelial myofibroblasts (sMF) are located underneath the urothelium in 
close proximity to afferent nerves and show spontaneous calcium activity in 
vivo and in vitro. They express purinergic receptors and calcium transients can 
be evoked by ATP. Therefore they are supposed to be involved in afferent 
signalling of the bladder fullness. The urothelium releases a number of 
signalling molecules onto stretch activation during the filling phase of the 
bladder. ATP, an important neurotransmitter, is released from the urothelium 
during bladder distension. This is presumably the first step in the excitation of 
bladder afferents as the bladder fills with urine. Since ATP concentration is 
likely to be very low during the initial filling phase, we hypothesized that sMF 
Ca2+ activity is affected even at very low ATP concentrations. 
In our experiments we found basic spontaneous calcium activity in 55.18% ± 
1.65 (mean ± SEM) of the sMF, with a mean amplitude of ΔFI = 243.9 ± 10.24 
F340nm/F380nm*1000 and an average Ca2+ peak frequency of 0.41 ± 0.01 
min-1 (n = 4039; N = 48). To the best of our knowledge, this is the first time to 
describe the information on the number of spontaneous activity in human 
myofibroblasts.  
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In present study we demonstrated that sMF Ca2+ activity was affected at very 
low ATP concentrations. Even sub-picomolar concentrations of extracellular 
ATP showed significant effects on the intracellular calcium activitiy in sMF. The 
kinetics of calcium transients varied at low and at high ATP concentrations. 
This means that even pico-molar concentrations of ATP, as expected during 
initial phase of bladder filling, can modulate the pattern of the spontaneous 
activity in sMF. 
ATP induced calcium transients of sMF were mimicked by α,β-methylene ATP 
(P2X1, P2X3 selective agonist), and confocal immunofluorescence analysis 
confirmed the expression of ionotropic P2X receptors in sMF, Calcium 
transients were only partially attenuated by TNP-ATP (P2X1, P2X3, and 
P2X2/3 selective) and  A-317491 (P2X3 selective) at both low and high ATP 
concentrations. At high ATP concentration (100µM) we found about 20% 
inhibition of the signal by A-317491 and about 40% inhibition by TNP-ATP. 
This indicates equal percentual contribution of P2X1 and P2X3 receptors. 
Interestingly the effects of antagonists were stronger at low ATP concentration 
(1pM). A-317491 showed about 40% inhibition and TNP-ATP inhibited up to 
75% of the ATP induced calcium amplitude. Those experiments demonstrate 
that P2X1 and P2X3 receptors are involved in ATP signaling in sMF. Due to 
lack of available P2X2 receptor antagonists, it remains unclear whether the 
P2X2 receptor is involved in ATP signaling as suggested by the high 
expression found in immunocytochemical examination. 
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In conclusion, Human cultured suburothelial myofibroblasts show spontaneous 
calcium activity and we demonstrate, for the first time, that ATP can modulate 
this spontaneous activity at very low ATP concentrations involving P2X 
receptors. These findings support the notion that sMF are competent, and very 
sensitive, to register bladder fullness, which predestines them for the 









7  References 
 
1. el-Badawi, A. and E.A. Schenk, Dual innervation of the mammalian urinary bladder. A 
histochemical study of the distribution of cholinergic and adrenergic nerves. Am J Anat, 1966. 
119(3): p. 405-27. 
2. Elbadawi, A., Functional anatomy of the organs of micturition. Urol Clin North Am, 1996. 
23(2): p. 177-210. 
3. Chang, S.L., et al., Roles of the lamina propria and the detrusor in tension transfer during 
bladder filling. Scand J Urol Nephrol Suppl, 1999. 201: p. 38-45. 
4. Inoue, T. and G. Gabella, The interface between epithelium and lamina propria in the rat 
urinary bladder. Arch Histol Cytol, 1992. 55 Suppl: p. 157-63. 
5. Wiseman, O.J., C.J. Fowler, and D.N. Landon, The role of the human bladder lamina propria 
myofibroblast. BJU Int, 2003. 91(1): p. 89-93. 
6. Thilagarajah, R., R.O. Witherow, and M.M. Walker, Quantitative histopathology can aid 
diagnosis in painful bladder syndrome. J Clin Pathol, 1998. 51(3): p. 211-4. 
7. Watanabe, T., et al., Comparative analysis of bladder wall compliance based on cystometry 
and biosensor measurements during the micturition cycle of the rat. Neurourol Urodyn, 1997. 
16(6): p. 567-81. 
8. Wein AJ, Kavoussi LR, and Novick AC, Pathophysiology and classification of voiding 
dysfunction. Campbell-Walsh Urology, 2007. 
9. de Groat, W.C. and N. Yoshimura, Pharmacology of the lower urinary tract. Annu Rev 
Pharmacol Toxicol, 2001. 41: p. 691-721. 
10. de Groat, W.C., et al., Neural control of the urethra. Scand J Urol Nephrol Suppl, 2001(207): 
p. 35-43; discussion 106-25. 
11. Hawthorn, M.H., et al., Urothelium-derived inhibitory factor(s) influences on detrusor muscle 
contractility in vitro. Br J Pharmacol, 2000. 129(3): p. 416-9. 
12. Andersson, A.K., M. Flodstrom, and S. Sandler, Cytokine-induced inhibition of insulin release 
from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase. Biochem 
Biophys Res Commun, 2001. 281(2): p. 396-403. 
13. Andersson, K.E., A role for nitric oxide synthase in urinary "urge syndrome". Nat Med, 1997. 
3(5): p. 502-4. 
14. Fall, M., et al., EAU guidelines on chronic pelvic pain. Eur Urol, 2010. 57(1): p. 35-48. 
15. Abrams, P., et al., The standardisation of terminology of lower urinary tract function: report 
from the Standardisation Sub-committee of the International Continence Society. Neurourol 
Urodyn, 2002. 21(2): p. 167-78. 
16. de Groat, W.C., A neurologic basis for the overactive bladder. Urology, 1997. 50(6A Suppl): 
p. 36-52; discussion 53-6. 
17. Branding, A. and W. Turner, The unstable bladder:towards a common mechanism. Br J Urol, 
1994. 73: p. 3-8. 
18. Brading, A., A myogenic basis for the overactive bladder. Urology, 1997. 50(6A Suppl): p. 
57-67; discussion 68-73. 
19. Drake, M.J., I.J. Harvey, and J.I. Gillespie, Autonomous activity in the isolated guinea pig 
Reference 46 
bladder. Exp Physiol, 2003. 88(1): p. 19-30. 
20. Drake, M., I. Mills, and J. Gillespie, Model of peripheral autonomous modules and a 
myovesical plexus in normal and overactive bladder function. Lancet, 2001. 358(9279): p. 
401-3. 
21. Apodaca, G., The uroepithelium: not just a passive barrier. Traffic, 2004. 5(3): p. 117-28. 
22. Birder, L., Role of the urothelium in bladder function. Scand J Urol Nephrol Suppl, 2004(215): 
p. 48-53. 
23. Wein, A.J., Role of the urothelium in bladder function. J Urol, 2005. 173(6): p. 2199-200. 
24. Lazzeri, M., The physiological function of the urothelium--more than a simple barrier. Urol 
Int, 2006. 76(4): p. 289-95. 
25. Wiseman, O., C. Fowler, and D. Landon, The role of the human bladder lamina propria 
myofibroblast. BJU Int, 2003. 91(1): p. 89-93. 
26. Sui, G., et al., Gap junctions and connexin expression in human suburothelial interstitial cells. 
BJU Int, 2002. 90(1): p. 118-29. 
27. Neuhaus, J., et al., [Structure and function of suburothelial myofibroblasts in the human 
urinary bladder under normal and pathological conditions.]. Urologe A, 2007. 46(9): p. 
1197-1202. 
28. Drake, M., C. Fry, and B. Eyden, Structural characterization of myofibroblasts in the bladder. 
BJU Int, 2006. 97(1): p. 29-32. 
29. Fry, C., et al., The function of suburothelial myofibroblasts in the bladder. Neurourol Urodyn, 
2007. 26(6 Suppl): p. 914-9. 
30. McCloskey, K.D., Interstitial cells in the urinary bladder--localization and function. 
Neurourol Urodyn, 2010. 29(1): p. 82-7. 
31. Roosen, A., et al., Characteristics of Spontaneous Activity in the Bladder Trigone. Eur Urol, 
2008. 
32. Ikeda, Y., et al., The Role of Gap Junctions in Spontaneous Activity of the Rat Bladder. Am J 
Physiol Renal Physiol, 2007: p. F1018-25. 
33. Neuhaus, J., et al., [Myofibroblasts and afferent signalling in the urinary bladder : A 
concept.]. Urologe A, 2008. 47(9): p. 1085-90. 
34. Scigalla F, et al., Analysis of mechanically evoked calcium signals in cultured human 
suburothelial myofibroblasts. Urologe A, 2009. 48(Suppl. 1): p. 15. 
35. Wu, C., G. Sui, and C. Fry, Purinergic regulation of guinea pig suburothelial myofibroblasts. 
J Physiol, 2004. 559(Pt 1): p. 231-43. 
36. Sui, G., C. Wu, and C. Fry, Characterization of the purinergic receptor subtype on guinea-pig 
suburothelial myofibroblasts. BJU Int, 2006. 97(6): p. 1327-31. 
37. Neuhaus, J., et al., Cholinergic and purinergic signaling in suburothelial myofibroblasts 
of the human bladder. Der Urologe, 2008. 47: p. 70. 
38. Smet, P.J., et al., Distribution of nitric oxide synthase-immunoreactive nerves and 
identification of the cellular targets of nitric oxide in guinea-pig and human urinary bladder 
by cGMP immunohistochemistry. Neuroscience, 1996. 71(2): p. 337-48. 
39. Chacko, S., et al., Contractile protein changes in urinary bladder smooth muscle following 
outlet obstruction. Adv Exp Med Biol, 1999. 462: p. 137-53. 
40. Fry, C.H., E. Meng, and J.S. Young, The physiological function of lower urinary tract smooth 
muscle. Auton Neurosci, 2010. 154(1-2): p. 3-13. 
Reference 47 
41. Hegde, S.S., Muscarinic receptors in the bladder: from basic research to therapeutics. Br J 
Pharmacol, 2006. 147 Suppl 2: p. S80-7. 
42. Elneil, S., et al., Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary 
bladder. Pharmacology, 2001. 63(2): p. 120-8. 
43. Sui, G., et al., Aberrant Ca2+ oscillations in smooth muscle cells from overactive human 
bladders. Cell Calcium, 2009. 45(5): p. 456-64. 
44. John, H., et al., Evidence of gap junctions in the stable nonobstructed human bladder. J Urol, 
2003. 169(2): p. 745-9. 
45. Neuhaus, J., et al., Smooth muscle cells from human urinary bladder express connexin 43 in 
vivo and in vitro. World J Urol, 2002. 20(4): p. 250-4. 
46. Haferkamp, A., et al., Increased expression of connexin 43 in the overactive neurogenic 
detrusor. Eur Urol, 2004. 46(6): p. 799-805. 
47. Neuhaus, J., et al., Alterations in connexin expression in the bladder of patients with urge 
symptoms. BJU Int, 2005. 96(4): p. 670-6. 
48. Birder, L.A., et al., Vanilloid receptor expression suggests a sensory role for urinary bladder 
epithelial cells. Proc Natl Acad Sci U S A, 2001. 98(23): p. 13396-401. 
49. Kunze, A., J. Neuhaus, and J.U. Stolzenburg, Quantitative immunohistochemical study of the 
innervation of the guinea-pig lower urinary tract. BJU Int, 2006. 98(2): p. 424-9. 
50. Lewis, S. and J. Lewis, Kinetics of urothelial ATP release. Am J Physiol Renal Physiol, 2006. 
291(2): p. F332-40. 
51. Gillespie, J., M. Markerink-van Ittersum, and J. De Vente, Endogenous nitric oxide/cGMP 
signalling in the guinea pig bladder: evidence for distinct populations of sub-urothelial 
interstitial cells. Cell Tissue Res, 2006. 325(2): p. 325-32. 
52. Sun, Y., et al., EGF and HB-EGF modulate inward potassium current in human bladder 
urothelial cells from normal and interstitial cystitis patients. Am J Physiol Cell Physiol, 2007. 
292(1): p. C106-14. 
53. Birder, L.A. and W.C. de Groat, Mechanisms of disease: involvement of the urothelium in 
bladder dysfunction. Nat Clin Pract Urol, 2007. 4(1): p. 46-54. 
54. Knowles, J.R., Enzyme-catalyzed phosphoryl transfer reactions. Annu Rev Biochem, 1980. 49: 
p. 877-919. 
55. Abbracchio, M.P., et al., Purinergic signalling in the nervous system: an overview. Trends 
Neurosci, 2009. 32(1): p. 19-29. 
56. Burnstock, G., Purinergic signalling: past, present and future. Braz J Med Biol Res, 2009. 
42(1): p. 3-8. 
57. Surprenant, A. and R. North, Signaling at Purinergic P2X Receptors. Annu Rev Physiol, 
2008. 
58. Burnstock, G., Purine-mediated signalling in pain and visceral perception. Trends Pharmacol 
Sci, 2001. 22(4): p. 182-8. 
59. Zhong, Y., P.M. Dunn, and G. Burnstock, Multiple P2X receptors on guinea-pig pelvic 
ganglion neurons exhibit novel pharmacological properties. Br J Pharmacol, 2001. 132(1): p. 
221-33. 
60. Burnstock, G. and M. Williams, P2 purinergic receptors: modulation of cell function and 
therapeutic potential. J Pharmacol Exp Ther, 2000. 295(3): p. 862-9. 
61. Lee, H., M. Bardini, and G. Burnstock, Distribution of P2X receptors in the urinary bladder 
Reference 48 
and the ureter of the rat. J Urol, 2000. 163(6): p. 2002-7. 
62. Valera, S., et al., Characterization and chromosomal localization of a human P2X receptor 
from the urinary bladder. Receptors Channels, 1995. 3(4): p. 283-9. 
63. O'Reilly, B., et al., A quantitative analysis of purinoceptor expression in human fetal and 
adult bladders. J Urol, 2001. 165(5): p. 1730-4. 
64. O'Reilly, B., et al., A quantitative analysis of purinoceptor expression in the bladders of 
patients with symptomatic outlet obstruction. BJU Int, 2001. 87(7): p. 617-22. 
65. Ferguson, D., I. Kennedy, and T. Burton, ATP is released from rabbit urinary bladder 
epithelial cells by hydrostatic pressure changes--a possible sensory mechanism? J Physiol, 
1997. 505 ( Pt 2): p. 503-11. 
66. Birder, L., et al., Altered urinary bladder function in mice lacking the vanilloid receptor 
TRPV1. Nat Neurosci, 2002. 5(9): p. 856-60. 
67. Wang, E., et al., ATP and purinergic receptor-dependent membrane traffic in bladder 
umbrella cells. J Clin Invest, 2005. 115(9): p. 2412-22. 
68. Cockayne, D.A., et al., Urinary bladder hyporeflexia and reduced pain-related behaviour in 
P2X3-deficient mice. Nature, 2000. 407(6807): p. 1011-5. 
69. Vlaskovska, M., et al., P2X3 knock-out mice reveal a major sensory role for urothelially 
released ATP. J Neurosci, 2001. 21(15): p. 5670-7. 
70. Sugaya, K. and W.C. de Groat, Influence of temperature on activity of the isolated whole 
bladder preparation of neonatal and adult rats. Am J Physiol Regul Integr Comp Physiol, 
2000. 278(1): p. R238-46. 
71. Streng, T., et al., Phasic non-micturition contractions in the bladder of the anaesthetized and 
awake rat. BJU Int, 2006. 97(5): p. 1094-101. 
72. Gillespie, J.I., I.J. Harvey, and M.J. Drake, Agonist- and nerve-induced phasic activity in the 
isolated whole bladder of the guinea pig: evidence for two types of bladder activity. Exp 
Physiol, 2003. 88(3): p. 343-57. 
73. Gillespie, J., Modulation of autonomous contractile activity in the isolated whole bladder of 
the guinea pig. BJU Int, 2004. 93(3): p. 393-400. 
74. Kumar, V., et al., Recent advances in basic science for overactive bladder. Curr Opin Urol, 
2005. 15(4): p. 222-6. 
75. Andersson, K.E. and A. Arner, Urinary bladder contraction and relaxation: physiology and 
pathophysiology. Physiol Rev, 2004. 84(3): p. 935-86. 
76. Heinrich M, et al., Cytokine effects on gap junction communication and connexin expression 
in human bladder smooth muscle cells and suburothelial myofibroblasts. PLoS ONE, 2011. in 
press. 
77. McCloskey, K. and A. Gurney, KIT positive cells in the guinea pig bladder. J Urol, 2002. 
168: p. 832-836. 
78. Davidson, R. and K. McCloskey, Morphology and localization of interstitial cells in the 
guinea pig bladder: structural relationships with smooth muscle and neurons. J Urol, 2005. 
173(4): p. 1385-90. 
79. Maeda, H., et al., Requirement of c-kit for development of intestinal pacemaker system. 
Development, 1992. 116(2): p. 369-75. 
80. Roosen, A., et al., Suburothelial Myofibroblasts in the Human Overactive Bladder and the 
Effect of Botulinum Neurotoxin Type A Treatment. Eur Urol, 2008. 
Reference 49 
81. Skalli, O., et al., Myofibroblasts from diverse pathologic settings are heterogeneous in their 
content of actin isoforms and intermediate filament proteins. Lab Invest, 1989. 60(2): p. 
275-85. 
82. Mills, I., et al., Studies of the pathophysiology of idiopathic detrusor instability the 
physiological properties of the detrusor smooth muscle and its pattern of innervation. J 
Urology, 2000. 163: p. 646-651. 
83. Oger, S., et al., Effects of potassium channel modulators on myogenic spontaneous phasic 
contractile activity in human detrusor from neurogenic patients. BJU Int, 2010. 
84. Sui, G., et al., Modulation of bladder myofibroblast activity: implications for bladder function. 
Am J Physiol Renal Physiol, 2008. 
85. Akino, H., et al., Spontaneous contractions of the pig urinary bladder: the effect of 
ATP-sensitive potassium channels and the role of the mucosa. BJU Int, 2008. 102(9): p. 
1168-74. 
86. Meng, F., et al., Calcium oscillations induced by ATP in human umbilical cord smooth muscle 
cells. J Cell Physiol, 2007. 213(1): p. 79-87. 
87. Liang, W., et al., P2Y2 receptor-mediated Ca2+ signaling and spontaneous Ca2+ releases in 
human valvular myofibroblasts. Int Heart J, 2008. 49(2): p. 221-36. 
88. Liu, X., et al., Inhibition of ATP-induced Ca2+ influx by corticosterone in dorsal root 
ganglion neurons. Neurochem Res, 2010. 35(5): p. 804-10. 
89. Valera, S., et al., A new class of ligand-gated ion channel defined by P2x receptor for 
extracellular ATP. Nature, 1994. 371(6497): p. 516-9. 
90. Chen, C.C., et al., A P2X purinoceptor expressed by a subset of sensory neurons. Nature, 1995. 
377(6548): p. 428-31. 
91. Mahoney, M., et al., Time course of the initial [Ca2+]i response to extracellular ATP in 
smooth muscle depends on [Ca2+]e and ATP concentration. Biophy. J., 1998. 75: p. 2050-8. 
92. Ralevic, V. and G. Burnstock, Receptors for purines and pyrimidines. Pharmacol Rev, 1998. 
50(3): p. 413-92. 
93. Liu, F., N. Takahashi, and O. Yamaguchi, Expression of P2X3 purinoceptors in suburothelial 
myofibroblasts of the normal human urinary bladder. Int J Urol, 2009. 16(6): p. 570-5. 
94. Jarvis, M.F. and B.S. Khakh, ATP-gated P2X cation-channels. Neuropharmacology, 2009. 
56(1): p. 208-15. 
95. North, R.A. and A. Surprenant, Pharmacology of cloned P2X receptors. Annu Rev Pharmacol 









Declaration of original authorship 
 
Hereby I declare that I created this work independently and without illegitimate 
help. All information derived from the published and unpublished work of 
others has been clearly referenced in the text and the bibliography or 
references.  
 
I ensure that I have not sought or used the services of any professional 
agencies to produce this work. 
 
Further I ensure, that this dissertation has not been submitted for a higher 
degree to any other University or Institution. 
 




























Foremost, I am heartily thankful to my supervisor Priv.-Doz. Dr. Jochen 
Neuhaus, the head of the Research laboratory of the Department of Urology, 
University of Leipzig, without whom the current project could not have been 
accomplished. He designed this interesting scientific project, and has chosen 
me to work on it. He offered me continuous support during my PhD study and 
his guidance helped me during the all time of research and writing the thesis. 
His patience, motivation, enthusiasm, and immense knowledge impressed me 
deeply and will benefit my whole life. 
 
I would like to express my sincere gratitude to Prof. Dr. J-U Stolzenburg, the 
chief of the Department of Urology, University of Leipzig, for his endless 
support of my project and persistent encouragement. In addition, I would like to 
thank him to give me the best chance to learn the advanced laproscopic 
techniques, especially in extraperitoneal endoscopic radical prostatectomy. 
 
I would like to thank Frank Scigalla and Pietro Speroni di Fenizio for their great 
helpful instructions in calcium imaging experiments and data analysis. I also 
want to thank Mrs A. Weimann and Mrs M. Berndt for the excellent technical 
assistance. 
 
Last but not the least, I would like to thank my wife, Mufeng Xiang, and my 
parents. They take care of our little daughter and provide me with an endless 
support and encouragement.  
 
I am sure that my life and work here will be one of the happiest memories. 
 
 
 
 
 
 
 
 
 
 
 
 
